Fig. 4
From: The cost-utility of early use of high-flow nasal cannula in bronchiolitis
Population EVPI. *In red EVPI (US$ 19,000) for a Colombian threshold (3 times GDP per capita)
Fig. 4 | Health Economics Review
From: The cost-utility of early use of high-flow nasal cannula in bronchiolitis
Population EVPI. *In red EVPI (US$ 19,000) for a Colombian threshold (3 times GDP per capita)